NCBiotech News

We work hard to bring you the stories about the life science community in North Carolina. Every once in a while, we add a little news of our own. Read some of those stories below, or check out some of our perspectives on our staff blog.

IQVIA logo

Thirty-five years after its founding in 1982, Durham-based QuintilesIMS has retired its name for a new one, IQVIA (pronounced as “I-Q-via”).

Shares of IQVIA will trade on the New York Stock Exchange under the new ticker symbol IQV, effective Nov. 15.

Locus Biosciences logo
Locus Biosciences, born with the help of two loans from the North Carolina Biotechnology Center, has raised $19 million in Series A funding from major investors.

Are you ready for chicken tenders that taste and chew like the real thing, even though they’re made from plant protein without a bit of chicken? A Triangle-based company, Improved Nature, already has them and other plant-based meat-like products on the market.

That was only one of the advanced food technologies discussed by a panel of innovators at the North Carolina Professional Ag Biotech forum Wednesday at the North Carolina Biotechnology Center.

Others included:

Arbiom LogoWood, the traditional source of pulp, paper, packaging, biofuels and other industrial products, may soon find its way into fish feed bins and onto dinner plates with the use of new processing technologies developed by a North Carolina biotechnology company.

RedHill Biopharma logo
RedHill Biopharma, an Israeli company with U.S. headquarters in Raleigh, has received orphan drug designation for its pancreatic drug candidate from the U.S. Food and Drug Administration.
Syngenta logo
Swiss-based Syngenta, which has its U.S. headquarters in Greensboro and its Advanced Crop Lab in Research Triangle Park, has obtained a non-exclusive license from the Broad Institute of MIT and Harvard to use CRISPR-Cas9 genome editing technology for agriculture applications.
Baebies SEEKER diagnostic system - Baebies photo
Baebies SEEKER diagnostic system -- Baebies photo

Durham-based Baebies Inc., a developer of products and services for newborn screening and pediatric testing, has closed on $10 million in Series B financing.

The North Carolina Biotechnology Center awarded 28 grants, loans and fellowships totaling $1.8 million in the first quarter of its 2017-2018 fiscal year ending Sept. 30.
North Carolina companies presenting at the 19th annual Southeast BIO Investor & Partnering Forum offer participants access to technologies to treat heart arrhythmias, lung disease, glaucoma, bacterial infections, and addiction.

The Southeast BIO (SEBIO) Investor & Partnering Forum expects more than 300 biotech and medtech investors, executives, university representatives and entrepreneurs at its 2017 event in Pinehurst November 14 to 16.

Celebrating its 19th year, the SEBIO Investor & Partnering Forum has built a loyal following, attracting thought leaders and investors from across the country. Registration is available at the door.

“They call us the food police.”

That’s how Greg Jaffe described his work as director of biotechnology for the Center for Science in the Public Interest (CSPI), speaking at the North Carolina Biotechnology Center’s seventh annual Biotech Roundtable.

Unlike most speakers at the event, Jaffe said the U.S. government’s decision not to regulate some products created by gene editing is questionable.

Target PharmaSolutions logo

Clinical data company TARGET PharmaSolutions of Chapel Hill has entered into a new strategic partnership with a major pharmaceutical company and extended existing partnerships with two others to study a serious liver disease.

The Scullion Strategy Group, based in Greensboro, has inked an exclusive option agreement with Boston-based Brigham and Women’s Hospital (BWH) to license patent rights in semen analysis for veterinary use.

Morrisville-based TransEnterix has received clearance from the U.S. Food and Drug Administration to begin selling its Senhance surgical robotic system.